Intrinsiqq
Context Therapeutics Inc. logo

Context Therapeutics Inc. Insider Trading

CNTX

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jun 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Jun 2025
Jun 9, 2025

Get an email when CNTX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 9, 2025
    Martin A. Lehr
    Chief Executive Officer · bought 100,000 at $0.70
    70K
    10% of stake
  • Jun 6, 2025
    Alex C. Levit
    Chief Legal Officer, Corp. Sec · bought 20,000 at $0.58
    12K
    32% of stake
  • Jun 6, 2025
    Jennifer Lynn Minai-Azary
    Chief Financial Officer · bought 40,010 at $0.64
    26K
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CNTX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CNTX

CompareIntrinsic value
GANXGain Therapeutics Inc.
$1.00-4.86%25
KURAKura Oncology Inc.
$6.91-5.99%10
IRDOpus Genetics Inc.
$3.99-2.21%10
PVCTProvectus Biopharmaceuticals, Inc.
$0.05+1.11%6
VSTMVerastem Inc.
$6.33-7.73%40
LXRXLexicon Pharmaceuticals, Inc.
$1.53-8.38%40
COLLCollegium Pharmaceutical Inc.
$24.72-1.94%85
SVRASavara Inc.
$4.26-18.23%10

Spot a number that looks wrong? Check it in CNTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CNTX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.